ADVERTISEMENT

404

Not Found

Is this what you were looking for?

tag biobusiness business cell molecular biology industry

Green and red fluorescent proteins in a zebrafish outline the animal’s vasculature in red and lymphatic system in green in a fluorescent image. Where the two overlap along the bottom of the animal is yellow.
Serendipity, Happenstance, and Luck: The Making of a Molecular Tool
Shelby Bradford, PhD | Dec 4, 2023 | 10+ min read
The common fluorescent marker GFP traveled a long road to take its popular place in molecular biology today.
computing a cure
Artificial Intelligence Shakes Up Drug Discovery
Bianca Nogrady | May 1, 2019 | 8 min read
The pharmaceutical industry is looking to machine learning to overcome complex challenges in drug development.
A vet and technician take a sample from a dog for use in PetDx’s OncoK9 test, which screens cell-free DNA for genomic alterations associated with cancer.
The Pet Health Industry Takes on Canine Cancer
Diana Kwon | Oct 17, 2022 | 9 min read
Advanced genomic tools have provided biotech companies new approaches to help our furry friends—but experts say several limitations remain.
Women looks at computer screen in a lab coat and mask
Quest for Research Freedom Fuels African Biotech Boom
Linda Nordling | Jul 1, 2021 | 6 min read
Tired of dancing to the tunes of international funders, and doubtful that long-promised national grants will come, a handful of African biomedical scientists have turned to private investors to bankroll their dreams of autonomy in the lab.
Variation in Cannabis Testing Challenges a Young Industry
Katarina Zimmer | Mar 1, 2020 | 10 min read
The US lacks standardized methods to assess products for potency and safety. That’s a big problem for the labs tasked with doing the testing.
Keeping Up with IP
Kate Yandell | Sep 1, 2014 | 8 min read
It’s never too early to start thinking about intellectual property rights—even for biologists doing basic research.
Betting on Biotech
Scott Veggeberg | Apr 5, 1993 | 10 min read
Despite chill winds on Wall Street, investors continue to place bets on fledgling biotechnology companies.
Illustration of DNA
Can “Gene Writing” Deliver What Gene Editing Can’t?
Dan Robitzski | Dec 12, 2022 | 10+ min read
A biotech startup called Tessera Therapeutics has made a splash with its claims about the trademarked technology. Is the excitement justified?
Banking on iPSCs
Kerry Grens | Jun 29, 2014 | 6 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.
Banking on iPSCs
Kerry Grens | Sep 1, 2014 | 5 min read
A flurry of induced pluripotent stem cell banks are coming online, but they face significant business challenges.

Run a Search

ADVERTISEMENT